Search Results for: lung cancer

Almac and Lilly UK have entered into a partnership to develop a companion diagnostic for ALIMTA, with cisplatin, as a combination therapy for non-squamous non-small cell lung cancer.

Complete Genomics Inc, a third-generation human genome sequencing company, announced today that it has sequenced, analyzed and delivered 14 human genomes to customers since March 2009

Abbott announced that it has entered into an agreement with Pfizer Inc to develop a molecular diagnostic test intended to screen non-small cell lung cancer (NSCLC) tumors for the presence of gene rearrangements.

Gen-Probe Incorporated (NASDAQ: GPRO) announced that the Company has begun a clinical trial intended to secure U.S. regulatory approval of its PROGENSA PCA3 assay, a new molecular test that may help determine the need for a repeat prostate biopsy.

AMDL Inc announces the inauguration of AMDL Diagnostics Inc (ADI), a new wholly-owned subsidiary that will focus on the research, development, manufacture and international sales of Onko-SureAMDL’s proprietary, regulatory approved in vitro diagnostic (IVD) cancer test.